Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga PSMA-HBED-CC in Intermediate to High-Risk Preprostatectomy Patients

NCT03388346 is registered in ClinicalTrials.gov with Michael Graham PhD, MD as lead sponsor.

NCT NCT03388346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03388346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga PSMA-HBED-CC in Intermediate to High-Risk Preprostatectomy Patients
Lead sponsor
Michael Graham PhD, MD
Phase
Phase 2/3
Overall status
Completed
Start date
February 16, 2018
Completion date
July 22, 2021
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostatic neoplasm, prostatic neoplasm of uncertain behavior, prostatic neoplasms, castration-resistant